Rare disease biology
Build a clear scientific foundation for the program and the questions it needs to answer.
- Disease biology and mechanism assessment
- Scientific literature and evidence synthesis
- Identification of knowledge gaps
Rare disease · Preclinical · Translational
Translating rare disease biology into development strategy.
Scientific perspective for biotech companies and rare disease organizations turning complex biology into actionable development plans.
Start a conversationKRISTEN SKVORAK, PhD · RAREVANTAGE CONSULTING
The RareVantage perspective
Clarity for the next development decision.
Rare disease programs begin with distinct biology and difficult questions. RareVantage brings a focused scientific perspective to help teams connect disease understanding, preclinical evidence, and translational goals—then identify a practical path forward.
Consulting focus
From biological insight to a development plan.
Support shaped around your program, its scientific questions, and the decisions ahead.
Preclinical strategy
Connect research priorities to the evidence needed for the next development decision.
- Preclinical study strategy and planning
- Model and endpoint considerations
- Interpretation of emerging program data
Translational planning
Bring biological context and development objectives together in a coherent path forward.
- Translational questions and evidence gaps
- Biomarker and endpoint strategy
- Scientific communication and development roadmaps
Your scientific partner
A focused perspective.
A collaborative approach.
Kristen Skvorak, PhD
Preclinical & Translational Development Consultant
RareVantage Consulting supports biotech companies and rare disease organizations in translating biology into actionable preclinical and development strategies.
Engagements begin with your scientific question and the decision you need to make. Together, we can assess the evidence, clarify the gaps, and shape the next steps around your program’s needs.
Start with the question that matters.
Whether you are defining a research direction, evaluating preclinical findings, or planning the next stage of development, a focused conversation is a useful place to begin.
Let’s connect
What’s next for
your program?
Share the scientific challenge or development question you’re working through, and let’s discuss how RareVantage can help.